<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">J Neurooncol</journal-id>
      <journal-title>Journal of Neuro-Oncology</journal-title>
      <issn pub-type="ppub">0167-594X</issn>
      <issn pub-type="epub">1573-7373</issn>
      <publisher>
        <publisher-name>Kluwer Academic Publishers-Plenum Publishers</publisher-name>
        <publisher-loc>New York</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">17256106</article-id>
      <article-id pub-id-type="pmc">1915654</article-id>
      <article-id pub-id-type="publisher-id">9321</article-id>
      <article-id pub-id-type="doi">10.1007/s11060-006-9321-z</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Original Paper</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Hemangioblastomatosis in a patient with von Hippel-Lindau disease</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author" corresp="yes">
          <name name-style="western">
            <surname>Hanse</surname>
            <given-names>M. C. J.</given-names>
          </name>
          <address>
            <phone>+31-402-397050</phone>
            <fax>+31-402-465512</fax>
            <email>monique.hanse@cze.nl</email>
          </address>
          <xref ref-type="aff" rid="Aff1">1</xref>
          <xref ref-type="aff" rid="Aff3">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Vincent</surname>
            <given-names>A.</given-names>
          </name>
          <xref ref-type="aff" rid="Aff2">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>van den Bent</surname>
            <given-names>M. J.</given-names>
          </name>
          <xref ref-type="aff" rid="Aff1">1</xref>
        </contrib>
        <aff id="Aff1"><label>1</label>Neuro-oncology Unit, Daniel den Hoed Cancer Centre, Erasmus University Medical Center, PO Box 5201, 3008 AE Rotterdam, The Netherlands </aff>
        <aff id="Aff2"><label>2</label>Department of Neurosurgery, Erasmus University Medical Center, PO Box 2040, 3000 CA Rotterdam, The Netherlands </aff>
        <aff id="Aff3"><label>3</label>Department of Neurology, Catharina Hospital, PO Box 1350, 5602 ZA Eindhoven, The Netherlands </aff>
      </contrib-group>
      <pub-date pub-type="epub">
        <day>26</day>
        <month>1</month>
        <year>2007</year>
      </pub-date>
      <pub-date pub-type="ppub">
        <month>4</month>
        <year>2007</year>
      </pub-date>
      <volume>82</volume>
      <issue>2</issue>
      <fpage>163</fpage>
      <lpage>164</lpage>
      <history>
        <date date-type="received">
          <day>29</day>
          <month>10</month>
          <year>2006</year>
        </date>
        <date date-type="accepted">
          <day>14</day>
          <month>12</month>
          <year>2006</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; Springer Science+Business Media, LLC 2007</copyright-statement>
      </permissions>
      <kwd-group>
        <title>Keywords</title>
        <kwd>Von Hippel-Lindau disease</kwd>
        <kwd>Hemangioblastoma</kwd>
      </kwd-group>
      <custom-meta-wrap>
        <custom-meta>
          <meta-name>issue-copyright-statement</meta-name>
          <meta-value>&#xA9; Springer Science+Business Media, LLC 2007</meta-value>
        </custom-meta>
      </custom-meta-wrap>
    </article-meta>
  </front>
  <body>
    <sec id="Sec1" sec-type="introduction">
      <title>Case presentation</title>
      <p>A woman developed a cerebellar hemangioblastoma in 1991 at the age of 17 and von Hippel-Lindau disease was diagnosed. She underwent five craniotomies for recurrent hemangioblastoma. In 2001 she had a laminectomy for an intramedullar hemangioblastoma at C2-C3 level. In 2004 a renal cell carcinoma was found and a partial nephrectomy was performed. A few weeks after her last craniotomy in July 2005 she developed progressive right hemisensory disturbances and sensory ataxia. Spinal MRI showed leptomeningeal contrast enhancement around the entire spinal cord (see <xref rid="Fig1" ref-type="fig">Figure</xref>). The sensory ataxia progressed and she got tetraparesis, most severe proximally in her arms, especially myotome C4. Although hemangioblastoma are not very radiosensitive, radiotherapy was started because of the rapid clinical deterioration. High-dose total neuraxis radiotherapy was considered to toxic. It was judged that most of her clinical complaints could be attributed to the cervical spine. Also the MRI showed the most severe lesions at the cervical region. Therefore she was treated from C1 to Th1 (30&#xA0;&#xD7;&#xA0;1.8&#xA0;Gy) combined with dexamethasone (2&#xA0;&#xD7;&#xA0;8&#xA0;mg). During radiotherapy she developed also symptoms outside the radiotherapy field (thoracal radiculopathy).</p>
      <p>As the main problem in VHL is uncontrolled angiogenesis by overexpressing VEGF and VEGF receptors, Thalidomide (400&#xA0;mg, later 600&#xA0;mg) was added. Thalidomide inhibits angiogenesis induced by VEGF [<xref ref-type="bibr" rid="CR1">1</xref>]. Despite the treatment she developed a total tetraplegia and died 3&#xA0;months after diagnosis as a result of respiratory failure.</p>
      <p>This syndrome appears to result from delayed growth of subarachnoid tumor cells disseminated by surgery. Hemangioblastomatosis is also seen in hemangioblastoma patients without von Hippel-Lindau disease and it is thought that additional genes are likely to be the source of this malignant behaviour [<xref ref-type="bibr" rid="CR2">2</xref>].
              <fig id="Fig1"><graphic position="anchor" xlink:href="11060_2006_9321_Fig1_HTML" id="MO1"/></fig></p>
    </sec>
  </body>
  <back>
    <ref-list id="Bib1">
      <title>References</title>
      <ref id="CR1">
        <label>1.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Piribauer</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Czech</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Dieckmann</surname>
              <given-names>K</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Stabilization of a progressive hemangioblastoma under treatment with thalidomide</article-title>
          <source>J Neurooncol</source>
          <year>2004</year>
          <volume>66</volume>
          <fpage>295</fpage>
          <lpage>299</lpage>
          <pub-id pub-id-type="doi">10.1023/B:NEON.0000014493.88402.dc</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Piribauer M, Czech T, Dieckmann K et al. (2004) Stabilization of a progressive hemangioblastoma under treatment with thalidomide. J Neurooncol 66:295&#x2013;299 <pub-id pub-id-type="pmid">15015660</pub-id></citation>
      </ref>
      <ref id="CR2">
        <label>2.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Weil</surname>
              <given-names>RJ</given-names>
            </name>
            <name>
              <surname>Vortmeyer</surname>
              <given-names>AO</given-names>
            </name>
            <name>
              <surname>Zhuang</surname>
              <given-names>Z</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Clinical and molecular analysis of disseminated hemangioblastomatosis of the central nervous system in patients without von Hippel-Lindau disease</article-title>
          <source>J Neurosurg</source>
          <year>2002</year>
          <volume>96</volume>
          <fpage>775</fpage>
          <lpage>787</lpage>
        </citation>
        <citation citation-type="display-unstructured">Weil RJ, Vortmeyer AO, Zhuang Z et al. (2002) Clinical and molecular analysis of disseminated hemangioblastomatosis of the central nervous system in patients without von Hippel-Lindau disease. J Neurosurg 96:775&#x2013;787 <pub-id pub-id-type="pmid">11990821</pub-id></citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
